349 Tolerability of Tivozanib Vs. Sorafenib in Elderly And/or Immunotherapy-Pretreated Patients with Metastatic Renal Cell Cancer (mrcc) in TIVO-3
Journal for immunotherapy of cancer（2021）
Key words
Treatment
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined